These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 30840263)

  • 61. The relationship between the expression of Ki-67 and the prognosis of osteosarcoma.
    Zeng M; Zhou J; Wen L; Zhu Y; Luo Y; Wang W
    BMC Cancer; 2021 Mar; 21(1):210. PubMed ID: 33648449
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Analysis of circulating long non-coding RNA UCA1 as potential biomarkers for diagnosis and prognosis of osteosarcoma.
    Wen JJ; Ma YD; Yang GS; Wang GM
    Eur Rev Med Pharmacol Sci; 2017 Feb; 21(3):498-503. PubMed ID: 28239821
    [TBL] [Abstract][Full Text] [Related]  

  • 63. The prognostic value of long noncoding RNA HOTTIP on clinical outcomes in breast cancer.
    Yang Y; Qian J; Xiang Y; Chen Y; Qu J
    Oncotarget; 2017 Jan; 8(4):6833-6844. PubMed ID: 28036281
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Prognostic significance of relaxin-2 and S100A4 expression in osteosarcoma.
    Huang H; Zheng HY; Liu ZL; Zhang L
    Eur Rev Med Pharmacol Sci; 2014 Oct; 18(19):2828-34. PubMed ID: 25339476
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Long non-coding RNA CARLo-5 upregulation associates with poor prognosis in patients suffering gastric cancer.
    Liu JN; Shangguan YM
    Eur Rev Med Pharmacol Sci; 2017 Feb; 21(3):530-534. PubMed ID: 28239816
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Increased long noncoding RNA LINP1 expression and its prognostic significance in human breast cancer.
    Liu XM; Yang B; Han J
    Eur Rev Med Pharmacol Sci; 2018 Dec; 22(24):8749-8754. PubMed ID: 30575915
    [TBL] [Abstract][Full Text] [Related]  

  • 67. LncRNA WWOX‑AS1 inhibits the proliferation, migration and invasion of osteosarcoma cells.
    Qu G; Ma Z; Tong W; Yang J
    Mol Med Rep; 2018 Jul; 18(1):779-788. PubMed ID: 29845204
    [TBL] [Abstract][Full Text] [Related]  

  • 68. MALAT1 predicts poor survival in osteosarcoma patients and promotes cell metastasis through associating with EZH2.
    Huo Y; Li Q; Wang X; Jiao X; Zheng J; Li Z; Pan X
    Oncotarget; 2017 Jul; 8(29):46993-47006. PubMed ID: 28388584
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Expression of Leptin and Sirtuin-1 is associated with poor prognosis in patients with osteosarcoma.
    Feng H; Guo P; Wang J; Xu J; Xie C; Gao F
    Pathol Res Pract; 2016 Apr; 212(4):319-24. PubMed ID: 26936024
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Upregulation of SOX9 in osteosarcoma and its association with tumor progression and patients' prognosis.
    Zhu H; Tang J; Tang M; Cai H
    Diagn Pathol; 2013 Nov; 8():183. PubMed ID: 24188461
    [TBL] [Abstract][Full Text] [Related]  

  • 71. SP1-mediated upregulation of lncRNA ILF3-AS1 functions a ceRNA for miR-212 to contribute to osteosarcoma progression via modulation of SOX5.
    Hu XH; Dai J; Shang HL; Zhao ZX; Hao YD
    Biochem Biophys Res Commun; 2019 Apr; 511(3):510-517. PubMed ID: 30819403
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Elevated long non-coding RNA LINC00958 was associated with metastasis and unfavorable prognosis in gastric cancer.
    Wang W; Song ZJ; Wang Y; Zhong WF; Kang P; Yang Y
    Eur Rev Med Pharmacol Sci; 2019 Jan; 23(2):598-603. PubMed ID: 30720167
    [TBL] [Abstract][Full Text] [Related]  

  • 73. LncRNA BLACAT1 accelerates the proliferation and migration of osteosarcoma cells through regulating STAT3.
    Dong Z; Wang Y
    Pathol Res Pract; 2019 Mar; 215(3):571-579. PubMed ID: 30665678
    [TBL] [Abstract][Full Text] [Related]  

  • 74. An immune-related eleven-RNA signature-drived risk score model for prognosis of osteosarcoma metastasis.
    Teng JS; Wang Y
    Sci Rep; 2024 Jun; 14(1):13401. PubMed ID: 38862526
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Serum miR-542-3p as a prognostic biomarker in osteosarcoma.
    Li Q; Song S; Ni G; Li Y; Wang X
    Cancer Biomark; 2018 Feb; 21(3):521-526. PubMed ID: 29103020
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Long non-coding RNA tumor suppressor candidate 7 functions as a tumor suppressor and inhibits proliferation in osteosarcoma.
    Cong M; Li J; Jing R; Li Z
    Tumour Biol; 2016 Jul; 37(7):9441-50. PubMed ID: 26781978
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Does expression of glucose transporter protein-1 relate to prognosis and angiogenesis in osteosarcoma?
    Kubo T; Shimose S; Fujimori J; Furuta T; Arihiro K; Ochi M
    Clin Orthop Relat Res; 2015 Jan; 473(1):305-10. PubMed ID: 25193692
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Up-regulation of long noncoding RNA uc.338 predicts poor survival in non-small cell lung cancer.
    Tian Y; Feng Y
    Cancer Biomark; 2018; 22(4):781-785. PubMed ID: 29843223
    [TBL] [Abstract][Full Text] [Related]  

  • 79. The expression of Eps15 homology domain 1 is negatively correlated with disease-free survival and overall survival of osteosarcoma patients.
    Yu H; Qu G; Wang Y; Mai W; Bao JJ; Song C; Yao M
    J Orthop Surg Res; 2019 Apr; 14(1):103. PubMed ID: 30975166
    [TBL] [Abstract][Full Text] [Related]  

  • 80. The potential value of lncRNA-BC050642 in osteosarcoma origination and outcomes.
    Yang Y; Fei M; Zhou X; Li Y; Jin D
    Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):1859-1866. PubMed ID: 31397185
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.